申请人:Bristol-Myers Squibb Company
公开号:EP2289894A2
公开(公告)日:2011-03-02
Compounds having the formula (I), and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R1, R2, R3, R4, R5, R6, X and Z are as described in the specification.
具有式(I)的化合物及其药学上可接受的盐、原药和溶液可用作激酶抑制剂,其中 R1、R2、R3、R4、R5、R6、X 和 Z 如说明书所述。